Safety, tolerability, and efficacy of an in‐class combination therapy switch from bosentan plus sildenafil to ambrisentan plus tadalafil in children with pulmonary arterial hypertension.
Saved in:
| Title: | Safety, tolerability, and efficacy of an in‐class combination therapy switch from bosentan plus sildenafil to ambrisentan plus tadalafil in children with pulmonary arterial hypertension. |
|---|---|
| Authors: | Morgan, Cara1 (AUTHOR), Idris, Nikmah1 (AUTHOR), Elterefi, Kathy1 (AUTHOR), Di Ienno, Luca1 (AUTHOR), Constantine, Andrew2 (AUTHOR), Quyam, Sadia1,3 (AUTHOR), Bini, Roberta1 (AUTHOR), Moledina, Shahin1,3 (AUTHOR) s.moledina@ucl.ac.uk |
| Source: | Pulmonary Circulation. Oct2024, Vol. 14 Issue 4, p1-15. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20458932 |
|---|---|
| DOI: | 10.1002/pul2.70011 |
